Dr. Albert J. Deluca, MD

Dr. Deluca practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Deluca's NPI, 1376546523, was assigned on May 23, 2005. Dr. Deluca graduated from SUNY Downstate Health Sciences University in 1986. Dr. Deluca holds New York license 173000.

Dr. Deluca's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Deluca's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Deluca is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Deluca to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deluca practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Deluca's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Deluca is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Deluca is licensed in New York.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension, coronary artery disease and deep vein thrombosis (DVT) among the conditions Dr. Deluca treats.

CMS data shows 5,052 Medicare services from Dr. Deluca across 23 procedure codes in 2024, for 1,048 Medicare patients. Medicare paid $664,678 for them.

CMS counts 1,048 Medicare patients who saw Dr. Deluca in 2024. The largest group is 75 to 84, with 423 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deluca's median patient age at 68, with 37% women.

In 2024, Dr. Deluca wrote 5,070 Medicare Part D claims for 664 patients. 88% of them were for generic drugs. CMS names the drug for 4,788 of them, across 65 drugs with 11 or more claims each, at $739,371 in total drug cost. In 2023, CMS named 3,068 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Deluca for performance year 2024, reported through an alternative payment model (APM). Dr. Deluca accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Deluca, published from 2006 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Technetium Tc 99m Pyrophosphate, Radiopharmaceuticals and Amyloidosis. Dr. Deluca has published most often in Am J Cardiol. Dr. Deluca's most frequent co-authors are Mathew Shane Maurer, MD, Mona Parikh Kinkhabwala, MD and Lynne Lalor Johnson, MD.

CMS Open Payments shows 235 general payments to Dr. Deluca from 31 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 95% of the total. Boston Scientific Corporation paid the most, $971.

Dmand AI lists 2 awards for Dr. Deluca, most recently Top Doctors: New York Metro Area in 2018.

Dr. Deluca graduated from SUNY Downstate Health Sciences University in 1986. Dr. Deluca is a member of ACC.

Dr. Deluca is in network with 13 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.